33 assets in Hypertensive Disorder

Therapeutic assets addressing Hypertensive Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Hydrochlorothiazide Hypertensive Disorder	University of Kansas Medical Center	P4	BBB (77)
Valsartan Hypertensive Disorder	University of Alabama at Birmingham	P4	BBB (77)
Amlodipine Hypertensive Disorder	Jing Liu	P4	BBB (76)
Losartan Hypertensive Disorder	Rong Zhang	P4	BBB (76)
Candesartan Hypertensive Disorder	Augusta University	P4	BB (71)
Moxonidine Hypertensive Disorder	Vanderbilt University Medical Center	P4	BB (71)
Carvedilol Hypertensive Disorder	Kafrelsheikh University	P4	BB (69)
Folic Acid Hypertensive Disorder	Shenzhen Ausa Pharmed Co.,Ltd	P4	BB (69)
Nebivolol Hypertensive Disorder	Kafrelsheikh University	P4	BB (69)
Nicardipine Hypertensive Disorder	Universitas Sumatera Utara	P4	BB (67)
Sacubitril Hypertensive Disorder	Jing Liu	P4	BB (67)
Clevidipine Hypertensive Disorder	Zeenat Qureshi Stroke Institute	P4	BB (65)
Sacubitrilat Hypertensive Disorder	Novartis Pharmaceuticals	P3	BB (64)
L-5-MTHF Hypertensive Disorder	Shenzhen Ausa Pharmed Co.,Ltd	P4	B (62)
Umbellatine Hypertensive Disorder	China National Center for Cardiovascular Diseases	P4	B (62)
Vitamin D Hypertensive Disorder	Agricultural University of Athens	P2	B (61)
Mazdutide Hypertensive Disorder	Innovent Biologics (Suzhou) Co. Ltd.	P3	B (60)
Semaglutide Hypertensive Disorder	Mount Sinai Hospital, Canada	P3	B (60)
Orforglipron Hypertensive Disorder	Eli Lilly and Company	P3	B (57)
Sacubitril Valsartan Hypertensive Disorder	University of Alabama at Birmingham	P2/3	CCC (55)
cx11 Hypertensive Disorder	Vincentage Pharma Co., Ltd	P2	CCC (53)
Vigabatrin Hypertensive Disorder	University of Arizona	P2	CCC (53)
Talfirastide Hypertensive Disorder	Milton S. Hershey Medical Center	P1	CC (46)
Gly-Low Hypertensive Disorder	Hoskinson Health and Wellness Clinic	Early P1	CC (41)
ly3971297 Hypertensive Disorder	Eli Lilly and Company	P1	CC (41)
Neuropeptide Y Human Hypertensive Disorder	University of Texas Southwestern Medical Center	Early P1	C (38)
Chokeberry Juice Hypertensive Disorder	Medical University of Bialystok	N/A	D (30)
Labetalol Hypertensive Disorder	Universitas Sumatera Utara	N/A	D (30)
Lac Vaccinum Hypertensive Disorder	University of Toronto	N/A	D (30)
Tirzepatide Hypertensive Disorder	Cambridge University Hospitals NHS Foundation Trust	N/A	D (30)
Allisartan Hypertensive Disorder	Jing Liu	P4	NR ()
Hrs-7535 Hypertensive Disorder	Shandong Suncadia Medicine Co., Ltd.	P3	NR ()